Ribosome Display and Selection of Human Anti-Placental Growth Factor scFv Derived from Ovarian Cancer Patients
Authors:
- 1 May 2010
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Protein & Peptide Letters
- Vol. 17 (5) , 585-590
Abstract
Ribosome display is a powerful cell-free technology to select a desired antibody together with its encoding mRNA. In this study, a human single-chain variable fragment (scFv) library was generated from the peripheral blood lymphocyte RNA of 10 ovarian cancer patients and then panned against bead-conjugated human PlGF, a protein that may contribute to the growth and metastasis of ovarian cancer. A selected scFv antibody was evaluated by Western blot and its affinity constant to the PlGF was determined by noncompetitive enzyme immunoassay. This study highlights the ribosomal display technology for the selection of human antibody from patient-derived gene pools.Keywords
This publication has 9 references indexed in Scilit:
- Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy VesselsCell, 2007
- Selection of human anti-CD28 scFvs from a T-NHL related scFv library using ribosome displayJournal of Biotechnology, 2007
- Ribosome display: selecting and evolving proteins in vitro that specifically bind to a targetNature Methods, 2007
- Eukaryotic ribosome display with in situ DNA recoveryNature Methods, 2007
- Engineering of the Escherichia coli Im7 immunity protein as a loop display scaffoldProtein Engineering, Design and Selection, 2006
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Ribosome display of antibodies: expression, specificity and recovery in a eukaryotic systemJournal of Immunological Methods, 2005
- High-affinity binders selected from designed ankyrin repeat protein librariesNature Biotechnology, 2004
- Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassayJournal of Immunological Methods, 1987